Lexicon Pharmaceuticals

Lexicon Pharmaceuticals reports first-quarter loss but meets expectations
Yahoo/AP
Wed, 04/29/15 - 06:31 pm
Lexicon Pharmaceuticals
earnings
Lexicon tops Street 4Q forecasts
Yahoo/AP
Wed, 03/4/15 - 02:16 pm
Lexicon Pharmaceuticals
earnings
3 Small-Cap Biotechs That Institutions Are Loving
Yahoo/Benzinga
Mon, 07/7/14 - 07:30 pm
Infinity Pharmaceuticals
Vanda
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals up 25% on drug trial
Marketwatch
Mon, 04/14/14 - 08:14 am
Lexicon Pharmaceuticals
type 1 diabetes
LX4211
Lexicon Pharma to cut 45 pct of workforce, CEO to leave
Reuters
Mon, 01/13/14 - 10:50 am
Lexicon Pharmaceuticals
layoffs
Pharma CEOs
Arthur Sands
The Future of Diabetes Control: Treat the Cause, Not the Symptom
Wall St Cheat Sheet
Thu, 12/5/13 - 10:04 am
diabetes
Novo Nordisk
Prandin
Merck
Lexicon Pharmaceuticals
LX4211
PAZ320
Boston Therapeutics
Lexicon Completes Phase 2 Study Of LX1033 In IBS-d
Yahoo
Tue, 12/3/13 - 09:26 am
Lexicon Pharmaceuticals
IBS-d
LX1033
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks
The Street
Thu, 08/1/13 - 09:14 am
Lexicon Pharmaceuticals
LX4211
type 2 diabetes
diabetes
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
Which of These Billion-Dollar Biotechs Is a Buy?
Motley Fool
Sun, 06/2/13 - 11:45 am
Amarin
Lexicon Pharmaceuticals
Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership
TheStreet.com
Mon, 04/29/13 - 11:48 am
Merck
Pfizer
Lexicon Pharmaceuticals
diabetes
ertugliflozin
LX4211
US FDA grants fast track status to Lexicon's LX1033
Pharmaceutical Business Review
Mon, 12/24/12 - 10:55 am
FDA
Lexicon Pharmaceuticals
LX1033
D-IBS
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 11/3/12 - 11:31 am
Abiomed
Lexicon Pharmaceuticals
Corcept Therapeutics
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug
TheStreet.com
Tue, 10/16/12 - 10:40 am
diabetes
Lexicon Pharmaceuticals
LX4211
sodium-dependent glucose transporter
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Eli Lilly
Valeant Pharmaceuticals
Lexicon Pharmaceuticals
Sarepta Therapeutics
Amarin
NPS Pharmaceuticals
Aeterna Zentaris
Lexicon Pushes On To Phase III
Seeking Alpha
Sat, 10/13/12 - 12:24 pm
Lexicon Pharmaceuticals
LX1032
carcinoid syndrome
Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline
Yahoo/Reuters
Fri, 10/12/12 - 12:11 pm
diabetes
Lexicon Pharmaceuticals
carcinoid syndrome
LX1032
LX4211
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
PharmaLive
Sat, 08/18/12 - 04:07 pm
Lexicon Pharmaceuticals
LX2931
rheumatoid arthritis
LX7101
glaucoma
Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Yahoo/PR NewsWire
Sat, 06/9/12 - 12:29 pm
LX4211
Lexicon Pharmaceuticals
diabetes
type 2 diabetes

Pages